Skip to content

COBEA: what changed

BE 0465.667.997NACE 86.910, Medical imaging and medical laboratoriesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€5,219
2024 · €3,463-€8,682
Equity
€74,673
2024 · €79,892-€5,219
Cash
€1,682
2024 · €38,220-€36,537
Balance sheet total
€105,563
2024 · €118,216-€12,653

Largest movements

2024 to 2025
Assets
  • Cash -€36,537

    down €36,537 (-95.6%), from €38,220 to €1,682

    mainly Receivables within one year (-€23,972) and Other debts (-€7,435)

  • Receivables within one year +€23,972

    new in 2025: €23,972

Equity and liabilities
  • Other debts -€7,435

    down €7,435 (-19.4%), from €38,324 to €30,890

  • Profit (loss) carried forward -€5,219

    down €5,219 (-116%), from -€4,501 to -€9,720

Income statement
  • Purchases and services -€28,403

    no longer reported in 2025 (was €28,403)

  • Gross operating margin -€10,058

    down €10,058, from €6,000 to -€4,057

  • Other operating charges -€933

    down €933 (-46.9%), from €1,990 to €1,057

  • Depreciation -€397

    no longer reported in 2025 (was €397)

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €3,463
Gross operating margin -€10,058
Depreciation +€397
Other operating charges +€933
Financial income -€8
Financial charges +€51
Taxes +€2
Result 2025 -€5,219
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€36,537
Investment €0
Financing €0
Cash 2024 €38,220
Net result for the year -€5,219
Receivables within one year -€23,972
Deferred charges and accrued income +€88
Other debts -€7,435
Cash 2025 €1,682
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €118,216 €105,563 -€12,653 -10.7%
Fixed assets 21/28 €79,909 €79,909 = 0.0%
Financial fixed assets 28 €79,909 €79,909 = 0.0%
Current assets 29/58 €38,307 €25,654 -€12,653 -33.0%
Amounts receivable within one year 40/41 - €23,972 +€23,972
Other amounts receivable 41 - €23,972 +€23,972
Cash at bank and in hand 54/58 €38,220 €1,682 -€36,537 -95.6%
Deferred charges and accrued income 490/1 €88 - -€88
Total equity and liabilities 10/49 €118,216 €105,563 -€12,653 -10.7%
Equity 10/15 €79,892 €74,673 -€5,219 -6.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Contributions outside capital 11 €18,600 €18,600 = 0.0%
Other 1109/19 €18,600 €18,600 = 0.0%
Reserves 13 €65,793 €65,793 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €63,933 €63,933 = 0.0%
Profit (loss) carried forward 14 -€4,501 -€9,720 -€5,219 -116%
Amounts payable 17/49 €38,324 €30,890 -€7,435 -19.4%
Amounts payable within one year 42/48 €38,324 €30,890 -€7,435 -19.4%
Other amounts payable 47/48 €38,324 €30,890 -€7,435 -19.4%
Goods, raw materials, services and sundry goods 60/61 €28,403 - -€28,403
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €397 - -€397
Other operating charges 640/8 €1,990 €1,057 -€933 -46.9%
Gross operating margin 9900 €6,000 -€4,057 -€10,058
Operating profit (loss) 9901 €3,613 -€5,114 -€8,727
Financial income 75/76B €8 - -€8
Recurring financial income 75 €8 - -€8
Financial charges 65/66B €155 €104 -€51 -32.8%
Recurring financial charges 65 €155 €104 -€51 -32.8%
Profit (loss) for the period before taxes 9903 €3,466 -€5,219 -€8,684
Income taxes 67/77 €2 - -€2
Profit (loss) for the period 9904 €3,463 -€5,219 -€8,682
Profit (loss) for the period to be appropriated 9905 €3,463 -€5,219 -€8,682

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€74,673 to €74,673

Midpoint €74,673 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €74,673
Indication €74,673

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€74,673
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€74,673

Capitalised earnings

net result for the year (9904)
2025
-€5,219
2024
€3,463
2023
-€28,162
excluding non-recurring income and charges
-€28,204
2022
-€1,732
2021
-€2,106
Average result, excluding non-recurring income and charges
-€9,987
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.